PROVIDER PROFILE · NPI 1023166816
Mark Ewing
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
981
Beneficiaries
—
Total drug cost
$235K
Distinct drugs
20
Brand share
49.7%
Top prescribed drugs
Peg3350/Sod Sulf,bicarb,cl/Kcl311 claims
Omeprazole140 claims
Mesalamine121 claims
Pantoprazole Sodium76 claims
Plecanatide51 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Mark Ewing's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 1 outbound destinations.
Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| KAISER FOUNDATION HOSPITALS | 31 | 38 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE